Elizabeth Goldberg
Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 43 | 2026 | 2310 | 7.530 |
Why?
| | Accidental Falls | 14 | 2026 | 222 | 6.910 |
Why?
| | Patient Transfer | 7 | 2024 | 206 | 3.090 |
Why?
| | Nursing Homes | 4 | 2024 | 172 | 2.170 |
Why?
| | Dementia | 4 | 2025 | 303 | 1.910 |
Why?
| | Telemedicine | 5 | 2025 | 945 | 1.640 |
Why?
| | Aged | 46 | 2026 | 25913 | 1.560 |
Why?
| | Aged, 80 and over | 24 | 2026 | 8265 | 1.340 |
Why?
| | Caregivers | 4 | 2026 | 1049 | 1.320 |
Why?
| | Hypertension | 6 | 2019 | 1263 | 1.210 |
Why?
| | Documentation | 2 | 2024 | 198 | 1.210 |
Why?
| | Potentially Inappropriate Medication List | 3 | 2024 | 16 | 1.190 |
Why?
| | Medicare | 4 | 2023 | 886 | 1.070 |
Why?
| | Blood Pressure Determination | 4 | 2017 | 144 | 1.060 |
Why?
| | Referral and Consultation | 6 | 2026 | 851 | 1.030 |
Why?
| | Medicare Part C | 2 | 2018 | 31 | 0.980 |
Why?
| | Geriatrics | 3 | 2026 | 96 | 0.930 |
Why?
| | Qualitative Research | 7 | 2026 | 1671 | 0.920 |
Why?
| | Ethanol | 3 | 2025 | 627 | 0.880 |
Why?
| | Physicians | 4 | 2022 | 939 | 0.850 |
Why?
| | Rhode Island | 5 | 2026 | 31 | 0.850 |
Why?
| | Humans | 70 | 2026 | 144759 | 0.840 |
Why?
| | Mass Screening | 4 | 2026 | 1347 | 0.830 |
Why?
| | Patient Acceptance of Health Care | 2 | 2021 | 885 | 0.810 |
Why?
| | Medication Adherence | 3 | 2024 | 539 | 0.800 |
Why?
| | Patient Discharge | 4 | 2022 | 983 | 0.760 |
Why?
| | Transitional Care | 1 | 2023 | 46 | 0.760 |
Why?
| | Pharmacists | 2 | 2023 | 240 | 0.730 |
Why?
| | Male | 41 | 2026 | 72315 | 0.720 |
Why?
| | Emergency Medical Services | 5 | 2023 | 696 | 0.720 |
Why?
| | Electronic Health Records | 3 | 2025 | 1173 | 0.710 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2024 | 257 | 0.710 |
Why?
| | Terminal Care | 1 | 2025 | 279 | 0.700 |
Why?
| | Female | 41 | 2026 | 78271 | 0.680 |
Why?
| | Home Care Services | 1 | 2024 | 280 | 0.650 |
Why?
| | Drug Monitoring | 1 | 2024 | 395 | 0.640 |
Why?
| | Pandemics | 4 | 2022 | 1694 | 0.630 |
Why?
| | Inappropriate Prescribing | 4 | 2025 | 63 | 0.630 |
Why?
| | Hospitalization | 5 | 2023 | 2433 | 0.630 |
Why?
| | Coinfection | 1 | 2021 | 141 | 0.620 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 154 | 0.620 |
Why?
| | Quarantine | 1 | 2020 | 31 | 0.620 |
Why?
| | Preliminary Data | 1 | 2019 | 10 | 0.620 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.600 |
Why?
| | Social Media | 1 | 2022 | 171 | 0.590 |
Why?
| | Smartphone | 1 | 2020 | 102 | 0.580 |
Why?
| | Medication Therapy Management | 1 | 2019 | 73 | 0.570 |
Why?
| | Benzodiazepines | 3 | 2025 | 167 | 0.570 |
Why?
| | Physicians, Primary Care | 1 | 2021 | 207 | 0.570 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 68 | 0.560 |
Why?
| | Decision Making | 1 | 2025 | 975 | 0.540 |
Why?
| | Quality Indicators, Health Care | 2 | 2018 | 335 | 0.540 |
Why?
| | Mobile Applications | 1 | 2020 | 196 | 0.510 |
Why?
| | Skilled Nursing Facilities | 2 | 2023 | 151 | 0.510 |
Why?
| | Disease Outbreaks | 1 | 2020 | 422 | 0.490 |
Why?
| | Inventions | 1 | 2016 | 19 | 0.480 |
Why?
| | Renal Colic | 1 | 2016 | 4 | 0.480 |
Why?
| | Benchmarking | 1 | 2017 | 188 | 0.470 |
Why?
| | Coronavirus Infections | 2 | 2021 | 378 | 0.460 |
Why?
| | Wounds and Injuries | 3 | 2025 | 956 | 0.450 |
Why?
| | Prochlorperazine | 2 | 2025 | 10 | 0.450 |
Why?
| | Analgesia | 1 | 2016 | 105 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.440 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 340 | 0.440 |
Why?
| | Health Expenditures | 1 | 2016 | 194 | 0.430 |
Why?
| | Mortality | 1 | 2016 | 375 | 0.400 |
Why?
| | Length of Stay | 1 | 2019 | 1337 | 0.400 |
Why?
| | Altitude Sickness | 2 | 2025 | 141 | 0.400 |
Why?
| | Interviews as Topic | 3 | 2026 | 901 | 0.400 |
Why?
| | Anxiety | 1 | 2021 | 1109 | 0.400 |
Why?
| | Middle Aged | 16 | 2026 | 35875 | 0.390 |
Why?
| | Risk Assessment | 4 | 2026 | 3671 | 0.390 |
Why?
| | Surveys and Questionnaires | 5 | 2025 | 6048 | 0.390 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1185 | 0.390 |
Why?
| | Cannabinoids | 2 | 2025 | 182 | 0.380 |
Why?
| | Blood Pressure | 2 | 2019 | 1769 | 0.380 |
Why?
| | Hospitals | 1 | 2017 | 730 | 0.370 |
Why?
| | Drug Prescriptions | 2 | 2025 | 284 | 0.360 |
Why?
| | United States | 11 | 2024 | 15966 | 0.360 |
Why?
| | Patient Readmission | 1 | 2017 | 758 | 0.350 |
Why?
| | Artificial Intelligence | 2 | 2025 | 365 | 0.330 |
Why?
| | Continuity of Patient Care | 2 | 2024 | 291 | 0.320 |
Why?
| | Atrioventricular Block | 1 | 2010 | 45 | 0.300 |
Why?
| | Lyme Disease | 1 | 2010 | 58 | 0.300 |
Why?
| | Adult | 13 | 2025 | 40449 | 0.300 |
Why?
| | Geriatric Assessment | 3 | 2021 | 233 | 0.290 |
Why?
| | Emergency Medicine | 3 | 2021 | 261 | 0.290 |
Why?
| | Retrospective Studies | 10 | 2026 | 17066 | 0.290 |
Why?
| | Alcoholism | 2 | 2026 | 817 | 0.280 |
Why?
| | Quality of Life | 2 | 2024 | 3185 | 0.280 |
Why?
| | Pain Management | 2 | 2026 | 405 | 0.270 |
Why?
| | Risk Adjustment | 2 | 2017 | 85 | 0.240 |
Why?
| | Analgesics, Opioid | 2 | 2025 | 1143 | 0.240 |
Why?
| | Head and Neck Neoplasms | 2 | 2022 | 558 | 0.240 |
Why?
| | Risk Factors | 4 | 2025 | 10779 | 0.220 |
Why?
| | Nerve Block | 1 | 2026 | 103 | 0.210 |
Why?
| | Ultrasonography, Interventional | 1 | 2026 | 160 | 0.210 |
Why?
| | Tablets | 1 | 2024 | 41 | 0.210 |
Why?
| | Naltrexone | 1 | 2025 | 117 | 0.210 |
Why?
| | Cough | 2 | 2022 | 124 | 0.210 |
Why?
| | Delirium | 1 | 2025 | 104 | 0.200 |
Why?
| | Anaphylaxis | 1 | 2025 | 102 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2026 | 1095 | 0.200 |
Why?
| | Reproductive Health Services | 2 | 2020 | 18 | 0.200 |
Why?
| | Narration | 1 | 2024 | 75 | 0.200 |
Why?
| | Pilot Projects | 2 | 2019 | 1886 | 0.200 |
Why?
| | Eligibility Determination | 1 | 2023 | 68 | 0.190 |
Why?
| | Narcotic Antagonists | 1 | 2025 | 205 | 0.190 |
Why?
| | Delivery of Health Care | 2 | 2020 | 947 | 0.190 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 129 | 0.190 |
Why?
| | Pharmacies | 1 | 2023 | 42 | 0.190 |
Why?
| | Pharmacy | 1 | 2023 | 33 | 0.190 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3409 | 0.180 |
Why?
| | Tumor Escape | 1 | 2022 | 49 | 0.180 |
Why?
| | Comprehension | 1 | 2024 | 180 | 0.180 |
Why?
| | Pharmaceutical Services | 1 | 2023 | 78 | 0.180 |
Why?
| | Quality of Health Care | 3 | 2024 | 691 | 0.180 |
Why?
| | Delphi Technique | 1 | 2024 | 329 | 0.180 |
Why?
| | Asthma | 1 | 2013 | 1767 | 0.180 |
Why?
| | Internet | 2 | 2024 | 699 | 0.180 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5868 | 0.170 |
Why?
| | Prevalence | 3 | 2024 | 2834 | 0.170 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2025 | 497 | 0.170 |
Why?
| | Colorado | 3 | 2026 | 4564 | 0.170 |
Why?
| | Motivation | 1 | 2026 | 610 | 0.170 |
Why?
| | Primary Health Care | 2 | 2022 | 1733 | 0.170 |
Why?
| | Longevity | 1 | 2022 | 173 | 0.160 |
Why?
| | Health Services for Transgender Persons | 1 | 2020 | 3 | 0.160 |
Why?
| | Technology | 1 | 2021 | 95 | 0.160 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2020 | 9 | 0.160 |
Why?
| | Anticoagulants | 1 | 2025 | 722 | 0.160 |
Why?
| | Severe Acute Respiratory Syndrome | 1 | 2020 | 19 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.160 |
Why?
| | Independent Living | 1 | 2021 | 114 | 0.150 |
Why?
| | Goals | 1 | 2021 | 183 | 0.150 |
Why?
| | Triage | 2 | 2025 | 249 | 0.150 |
Why?
| | Mind-Body Therapies | 1 | 2019 | 9 | 0.150 |
Why?
| | Patient Reported Outcome Measures | 1 | 2024 | 488 | 0.150 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 108 | 0.150 |
Why?
| | Sexism | 1 | 2020 | 70 | 0.150 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 102 | 0.150 |
Why?
| | Medicaid | 1 | 2023 | 461 | 0.150 |
Why?
| | Contraception Behavior | 1 | 2020 | 107 | 0.150 |
Why?
| | Single-Blind Method | 1 | 2019 | 312 | 0.140 |
Why?
| | Physical Therapists | 1 | 2019 | 64 | 0.140 |
Why?
| | Clinical Trials as Topic | 1 | 2023 | 1053 | 0.140 |
Why?
| | Prospective Studies | 3 | 2025 | 7990 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1560 | 0.130 |
Why?
| | Women's Health | 1 | 2020 | 310 | 0.130 |
Why?
| | New England | 1 | 2017 | 37 | 0.130 |
Why?
| | Medical History Taking | 1 | 2017 | 117 | 0.130 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 641 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 332 | 0.130 |
Why?
| | Fee-for-Service Plans | 1 | 2017 | 98 | 0.130 |
Why?
| | Fear | 1 | 2020 | 366 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1356 | 0.120 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 194 | 0.120 |
Why?
| | Young Adult | 4 | 2025 | 14105 | 0.120 |
Why?
| | Colic | 1 | 2016 | 8 | 0.120 |
Why?
| | Secondary Prevention | 1 | 2017 | 254 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 529 | 0.120 |
Why?
| | Sexual and Gender Minorities | 1 | 2020 | 251 | 0.120 |
Why?
| | Adolescent | 4 | 2025 | 22428 | 0.110 |
Why?
| | Cohort Studies | 2 | 2025 | 5960 | 0.110 |
Why?
| | Choice Behavior | 1 | 2016 | 177 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 710 | 0.110 |
Why?
| | Needs Assessment | 1 | 2017 | 404 | 0.110 |
Why?
| | Health Services Accessibility | 2 | 2020 | 1098 | 0.110 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 461 | 0.110 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 289 | 0.100 |
Why?
| | Cancer Survivors | 1 | 2019 | 327 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2115 | 0.100 |
Why?
| | Self Report | 1 | 2017 | 872 | 0.100 |
Why?
| | Infant | 3 | 2017 | 10034 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2020 | 3604 | 0.090 |
Why?
| | Trauma Centers | 2 | 2025 | 462 | 0.090 |
Why?
| | Acute Disease | 2 | 2025 | 1030 | 0.090 |
Why?
| | Child, Preschool | 3 | 2017 | 11787 | 0.090 |
Why?
| | Kidney Diseases | 1 | 2016 | 427 | 0.090 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 251 | 0.080 |
Why?
| | Developing Countries | 1 | 2013 | 318 | 0.080 |
Why?
| | Sepsis | 1 | 2017 | 640 | 0.080 |
Why?
| | Sex Factors | 1 | 2017 | 2112 | 0.080 |
Why?
| | Pain | 1 | 2016 | 779 | 0.080 |
Why?
| | Ceftriaxone | 1 | 2010 | 21 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2025 | 2029 | 0.080 |
Why?
| | Child | 3 | 2017 | 22633 | 0.080 |
Why?
| | Reproductive Health | 2 | 2020 | 91 | 0.070 |
Why?
| | Quality Improvement | 1 | 2017 | 1289 | 0.070 |
Why?
| | Mutation | 1 | 2020 | 4089 | 0.070 |
Why?
| | Oxygen | 1 | 2013 | 995 | 0.070 |
Why?
| | Pneumonia | 1 | 2013 | 631 | 0.060 |
Why?
| | Communication | 1 | 2013 | 965 | 0.060 |
Why?
| | Electrocardiography | 1 | 2010 | 662 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2452 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1489 | 0.060 |
Why?
| | Medication Reconciliation | 1 | 2025 | 31 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2017 | 6429 | 0.060 |
Why?
| | Mountaineering | 1 | 2025 | 36 | 0.060 |
Why?
| | Parents | 1 | 2013 | 1403 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2017 | 2919 | 0.050 |
Why?
| | Epinephrine | 1 | 2025 | 155 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2025 | 600 | 0.050 |
Why?
| | Substance Abuse Detection | 1 | 2024 | 106 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2026 | 547 | 0.050 |
Why?
| | Retroelements | 1 | 2022 | 51 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2022 | 60 | 0.050 |
Why?
| | Internationality | 2 | 2013 | 156 | 0.050 |
Why?
| | Long-Term Care | 1 | 2023 | 117 | 0.040 |
Why?
| | Administration, Oral | 1 | 2024 | 847 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2023 | 124 | 0.040 |
Why?
| | Consensus | 1 | 2024 | 488 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 188 | 0.040 |
Why?
| | Decision Trees | 1 | 2021 | 81 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 140 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 223 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1985 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2025 | 11679 | 0.040 |
Why?
| | Carcinogens | 1 | 2020 | 122 | 0.040 |
Why?
| | Fever | 1 | 2021 | 311 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1907 | 0.040 |
Why?
| | Chromatin | 1 | 2022 | 561 | 0.030 |
Why?
| | Mice, Nude | 1 | 2020 | 682 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1720 | 0.030 |
Why?
| | Research | 1 | 2021 | 431 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3333 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2022 | 748 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 681 | 0.030 |
Why?
| | Pregnancy | 2 | 2020 | 7190 | 0.030 |
Why?
| | Histones | 1 | 2022 | 669 | 0.030 |
Why?
| | Transgender Persons | 1 | 2020 | 191 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1135 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1486 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2019 | 704 | 0.030 |
Why?
| | Mice | 2 | 2022 | 18339 | 0.030 |
Why?
| | Respiratory Rate | 1 | 2013 | 23 | 0.030 |
Why?
| | Rwanda | 1 | 2013 | 35 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7173 | 0.020 |
Why?
| | Hospitals, Rural | 1 | 2013 | 51 | 0.020 |
Why?
| | Area Under Curve | 1 | 2013 | 330 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2016 | 510 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2847 | 0.020 |
Why?
| | Registries | 1 | 2021 | 2385 | 0.020 |
Why?
| | ROC Curve | 1 | 2013 | 614 | 0.020 |
Why?
| | Health Resources | 1 | 2012 | 129 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2013 | 456 | 0.020 |
Why?
| | Animals | 2 | 2022 | 38058 | 0.020 |
Why?
|
|
Goldberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|